Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT06651853 2025-07-23

Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL

Phase 2 Recruiting

22 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00455897 2018-01-18

CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma

Phase 2 Terminated

3 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00073931 2015-02-05

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2 Completed

25 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00001237 2008-03-04

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

Phase 2 Completed

120 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse